# Regulation of Mitochondrial Biogenesis in Diabetic Retinopathy

**Authors:** Jay Kumar, Renu A. Kowluru

PMC · DOI: 10.3390/cells15040357 · 2026-02-17

## TL;DR

This study shows that the LncRNA HOTAIR plays a key role in mitochondrial dysfunction in diabetic retinopathy and contributes to its persistence even after blood sugar levels return to normal.

## Contribution

The study identifies HOTAIR as a novel regulator of mitochondrial biogenesis and metabolic memory in diabetic retinopathy.

## Key findings

- HOTAIR is upregulated in retinal cells under high glucose conditions and resists reversal after glucose levels normalize.
- Reducing HOTAIR with siRNA improves mitochondrial biogenesis and protects against structural/functional damage.
- Regulating HOTAIR during high glucose exposure prevents long-term mitochondrial dysfunction in retinal cells.

## Abstract

Mitochondrial dysfunction plays a major role in diabetic retinopathy development and in its resistance to halt after the reversal of hyperglycemia (metabolic memory). Diabetes also upregulates many long noncoding RNAs, RNAs with >200 nucleotides with no reading frame, and several of them resist reversal after hyperglycemia cessation. Our aim was to investigate the role of LncRNA HOTAIR, a master regulator of chromatin dynamics, in mitochondrial biogenesis in diabetic retinopathy and in metabolic memory. Using retinal endothelial cells and Müller cells, incubated in high glucose (20 mM D-glucose), the effect of HOTAIR-siRNA on mitochondrial biogenesis was investigated by quantifying mitochondrial mass, copy numbers, and mtDNA replication, structure, and function. HOTAIR’s role in metabolic memory was investigated by analyzing mitochondrial biogenesis in HOTAIR-siRNA transfected cells incubated in high glucose for four days, followed by normal glucose (5 mM D-glucose) for four days. HOTAIR was upregulated in both retinal vascular and nonvascular cells, and HOTAIR-siRNA ameliorated decreases in mtDNA biogenesis and protected their mitochondria from structural/functional damage. Reversal of high glucose insult failed to ameliorate HOTAIR upregulation and impaired mtDNA biogenesis in both endothelial and Müller cells, but regulation of HOTAIR during high glucose incubation, which followed normal glucose, prevented a decrease in mitochondrial mass and mtDNA copies. Thus, HOTAIR has a major role in mitochondrial biogenesis and in the continued impaired biogenesis in both vascular and nonvascular cells. Regulating HOTAIR may provide a therapeutic option to inhibit the development/progression of diabetic retinopathy.

## Linked entities

- **Genes:** HOTAIR (HOX transcript antisense RNA) [NCBI Gene 100124700]
- **Chemicals:** D-glucose (PubChem CID 5793)
- **Diseases:** diabetic retinopathy (MONDO:0005266)

## Full-text entities

- **Genes:** CYTB (cytochrome b) [NCBI Gene 4519] {aka MTCYB}, TF (transferrin) [NCBI Gene 7018] {aka HEL-S-71p, PRO1557, PRO2086, TFQTL1}, HOTAIR (HOX transcript antisense RNA) [NCBI Gene 100124700] {aka HOXAS, HOXC-AS4, HOXC11-AS1, NCRNA00072}, NEAT1 (nuclear paraspeckle assembly transcript 1) [NCBI Gene 283131] {aka LINC00084, NCRNA00084, TP53LC15, TncRNA, VINC}, TFAM (transcription factor A, mitochondrial) [NCBI Gene 7019] {aka MTDPS15, MTTF1, MTTFA, TCF6, TCF6L1, TCF6L2}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit) [NCBI Gene 2146] {aka ENX-1, ENX1, EZH2b, KMT6, KMT6A, WVS}, POLG (DNA polymerase gamma, catalytic subunit) [NCBI Gene 5428] {aka MIRAS, MTDPS4A, MTDPS4B, PEO, POLG1, POLGA}, KDM1A (lysine demethylase 1A) [NCBI Gene 23028] {aka AIMAH3, AOF2, BHC110, CPRF, KDM1, LSD1}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}
- **Diseases:** diabetic complication (MESH:D048909), hyperglycemic (MESH:D006944), Diabetic Retinopathy (MESH:D003930), neurovascular disorder (MESH:D013901), RMCs (MESH:D012173), Retinopathy (MESH:D058437), hypoxia (MESH:D000860), retinal detachment (MESH:D012163), vision loss (MESH:D014786), Mitochondrial dysfunction (MESH:D028361), injury to (MESH:D014947), hyperglycemia (MESH:D006943), Diabetes (MESH:D003920), endothelial dysfunction (MESH:D014652)
- **Chemicals:** paraformaldehyde (MESH:C003043), chloroform (MESH:D002725), antimycin A (MESH:D000968), agarose (MESH:D012685), osmium (MESH:D009992), glutamine (MESH:D005973), SYBR  Green (MESH:C098022), rotenone (MESH:D012402), CO2 (MESH:D002245), DAPI (MESH:C007293), D-glucose (MESH:D005947), formalin (MESH:D005557), Cy5 (MESH:C085321), oligomycin (MESH:D009840), 's lead (MESH:D007854), potassium ferrocyanide (MESH:C031835), glutaraldehyde (MESH:D005976), Texas Red (MESH:C034657), JC-1 (MESH:C068624), sodium citrate (MESH:D000077559), formamide (MESH:C031066), silicon (MESH:D012825), ABT-TC133L (-), thymidine (MESH:D013936), uranyl acetate (MESH:C005460), selenium (MESH:D012643), oil (MESH:D009821), dUTP (MESH:C027078), Lipofectamine (MESH:C086724), streptozotocin (MESH:D013311), TRIzol (MESH:C411644), phenol (MESH:D019800), cacodylate (MESH:D002101), glutamax (MESH:C054122), ethanol (MESH:D000431), FCCP (MESH:D002259), blood glucose (MESH:D001786), sodium hydroxide (MESH:D012972), HCl (MESH:D006851), isoamyl alcohol (MESH:C029683), lead nitrate (MESH:C017461), Oxygen (MESH:D010100), thiocarbohydrazide (MESH:C011368), pyruvate (MESH:D019289), saline (MESH:D012965), Triton X-100 (MESH:D017830), aphidicolin (MESH:D016590), BrDU (MESH:D001973)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939446/full.md

---
Source: https://tomesphere.com/paper/PMC12939446